Shengfang Ge
- Molecular Biology top 1%
- Cancer Research top 0.5%
- Oncology top 5%
- Ophthalmology top 0.5%
- Immunology top 5%
- Topics
- Ocular Oncology and Treatments (42 papers)Cancer-related molecular mechanisms research (23 papers)Epigenetics and DNA Methylation (23 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Shengfang Ge
191 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Molecular Biology 4.0k
- Cancer Research 2.5k
- Oncology 967
- Ophthalmology 770
- Immunology 626
Countries citing papers authored by Shengfang Ge
This map shows the geographic impact of Shengfang Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengfang Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengfang Ge more than expected).
Fields of papers citing papers by Shengfang Ge
This network shows the impact of papers produced by Shengfang Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengfang Ge. The network helps show where Shengfang Ge may publish in the future.
Co-authorship network of co-authors of Shengfang Ge
This figure shows the co-authorship network connecting the top 25 collaborators of Shengfang Ge. A scholar is included among the top collaborators of Shengfang Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengfang Ge. Shengfang Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 7 | |
| 5 | 3 | |
| 6 | 3 | |
| 7 | 21 | |
| 8 | 42 | |
| 9 | Metformin and cancer hallmarks: shedding new lights on therapeutic repurposingbreakdown → | 105 |
| 10 | 80 | |
| 11 | 1 | |
| 12 | 59 | |
| 13 | 114 | |
| 14 | 8 | |
| 15 | 34 | |
| 16 | 90 | |
| 17 | 19 | |
| 18 | 7 | |
| 19 | Therapeutic Efficacy By Targeting Correction Of Notch1-induced Aberrants In Uveal Tumors | 1 |
| 20 | 5 |
About Shengfang Ge
Shengfang Ge is a scholar working on Ophthalmology, Cancer Research and Molecular Biology, having authored 202 papers that have together received 6.5k indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (42 papers), Cancer-related molecular mechanisms research (23 papers) and Epigenetics and DNA Methylation (23 papers). The work is most often cited by research in Cancer Research (2.5k citations), Ophthalmology (770 citations) and Molecular Biology (4.0k citations). Shengfang Ge has collaborated with scholars based in China, United States and France. Frequent co-authors include Xianqun Fan, Renbing Jia, Peiwei Chai, Jie Yu, Jing Ruan, Zhi Yang, Renbing Jia, Minyue Xie, Qingfeng Shang and He Zhang. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.